159 related articles for article (PubMed ID: 3511660)
1. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
[TBL] [Abstract][Full Text] [Related]
2. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension.
Pool PE; Seagren SC; Salel AF
Am J Cardiol; 1985 Dec; 56(16):86H-91H. PubMed ID: 3907322
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release diltiazem: duration of antihypertensive effect.
Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; Dipette DJ; Evans RR
J Clin Pharmacol; 1989 Jun; 29(6):533-7. PubMed ID: 2666454
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
[TBL] [Abstract][Full Text] [Related]
5. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
8. Comparison of diltiazem and nifedipine for both angina pectoris and systemic hypertension.
Frishman WH; Charlap S; Goldberger J; Kimmel B; Stroh J; Dorsa F; Allen L; Strom J
Am J Cardiol; 1985 Dec; 56(16):41H-46H. PubMed ID: 3934948
[TBL] [Abstract][Full Text] [Related]
9. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
Wolfson P; Abernethy D; DiPette DJ; Zusman R
Am J Cardiol; 1988 Oct; 62(11):103G-108G. PubMed ID: 3051990
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L
Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317
[TBL] [Abstract][Full Text] [Related]
11. Comparative antihypertensive effectiveness of once-daily mibefradil and diltiazem CD. Mibefradil Hypertension Study Group.
Bittar N
Clin Ther; 1997; 19(5):954-62. PubMed ID: 9385483
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
13. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
[TBL] [Abstract][Full Text] [Related]
14. Optimization of antihypertensive therapy with a novel, extended-release formulation of diltiazem: results of a practice-based clinical study.
Neutel JM; Smith DH; Frishman WH
Clin Ther; 1997; 19(6):1379-93. PubMed ID: 9444447
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive therapy with diltiazem and comparison with hydrochlorothiazide.
Inouye IK; Massie BM; Benowitz N; Simpson P; Loge D
Am J Cardiol; 1984 Jun; 53(11):1588-92. PubMed ID: 6375339
[TBL] [Abstract][Full Text] [Related]
16. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerance of sustained-release diltiazem 300 mg and a diuretic in the elderly.
Djian J; Roy M; Forette B; Lekieffre J; Luccioni R
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S51-5. PubMed ID: 1706015
[TBL] [Abstract][Full Text] [Related]
18. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
19. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
Myburgh DP; Gordon NF
Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension.
Cushman WC; Cohen JD; Jones RP; Marbury TC; Rhoades RB; Smith LK
Am J Hypertens; 1998 Jan; 11(1 Pt 1):23-30. PubMed ID: 9504446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]